SCHEMBL17824312

SCHEMBL17824312

COCCNC(=O)Cn1c(NCc2ccccc2)nc2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.64
MEN1 O00255 1/20 0.64
PKM P14618 1/20 0.64
KMT2A Q03164 1/20 0.64
LMNA P02545 3/20 0.58
TSHR P16473 2/20 0.58
HTT P42858 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 4/20 0.53
DRD2 P14416 1/20 0.51
TBXA2R P21731 1/20 0.51
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP2C9 P11712 1/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.49
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19714240 0.94 RAB9A (0.59) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL19714188 0.94 RAB9A (0.61) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL19714421 0.92 DRD2 (0.63) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL17824305 0.91 RAB9A (0.54) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL17824271 0.90 RAB9A (0.53) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL19714135 0.89 RAB9A (0.61) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL19714637 0.89 RAB9A (0.61) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL19714603 0.89 MEN1 (0.60) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL17824290 0.88 PKM (0.62) RAB9AMEN1PKMKMT2ALMNA
SCHEMBL17824302 0.87 HTT (0.60) RAB9AMEN1PKMKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
EP-3230275-A1 PRO-SURVIVAL COMPOUNDS University Court of The University of Glasgow (GB) 2017-10-18 EP disclosed
WO-2016092327-A1 PRO-SURVIVAL COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS MCL1, MKI67, MORF4L1 RAB9A 2097/4885MEN1 2331/4885PKM 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.